Literature DB >> 12117897

Evaluating ERCP is important but difficult.

P B Cotton1.   

Abstract

ERCP is a valuable technique now practised widely throughout the world. It revolutionised the diagnosis and management of benign and malignant biliary and pancreatic diseases in the 1970s and 1980s. However, recent developments have highlighted the need for detailed evaluation of current ERCP practice. This review is based on a presentation to a recent NIH "state of the science" conference on ERCP, and refers to an article which appears in this issue of Gut from researchers in Hong Kong who report on a randomised controlled trial of endoscopic sphincterotomy in acute cholangitis.

Entities:  

Mesh：

Year:  2002        PMID： 12117897      PMCID： PMC1773300          DOI： 10.1136/gut.51.2.287

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  12 in total

Review 1.  Randomization is not the (only) answer: a plea for structured objective evaluation of endoscopic therapy.

Authors:  P B Cotton
Journal:  Endoscopy       Date:  2000-05       Impact factor: 10.093

Review 2.  National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.

Authors:  Sidney Cohen; Bruce R Bacon; Jesse A Berlin; David Fleischer; Gail A Hecht; Patrick J Loehrer; Alfred E McNair; Michael Mulholland; Nancy J Norton; Linda Rabeneck; David F Ransohoff; Amnon Sonnenberg; Michael W Vannier
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

3.  Of mice but not men. Problems of the randomized clinical trial.

Authors:  S Hellman; D S Hellman
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

4.  Therapeutic gastrointestinal endoscopy. Problems in proving efficacy.

Authors:  P B Cotton
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

5.  Endoscopic biliary drainage for severe acute cholangitis.

Authors:  E C Lai; F P Mok; E S Tan; C M Lo; S T Fan; K T You; J Wong
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

6.  Clinical trials--are they ethical?

Authors:  E Passamani
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

7.  Complications of endoscopic biliary sphincterotomy.

Authors:  M L Freeman; D B Nelson; S Sherman; G B Haber; M E Herman; P J Dorsher; J P Moore; M B Fennerty; M E Ryan; M J Shaw; J D Lande; A M Pheley
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

8.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

9.  A randomised controlled trial of endoscopic sphincterotomy in acute cholangitis without common bile duct stones.

Authors:  C-K Hui; K-C Lai; W-M Wong; M-F Yuen; S-K Lam; C-L Lai
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

10.  Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice.

Authors:  A G Speer; P B Cotton; R C Russell; R R Mason; A R Hatfield; J W Leung; K D MacRae; J Houghton; C A Lennon
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.